Trichloroethylene risk assessment: A review and commentary

David J. Jollow, James V. Bruckner, David C. McMillan, Jeffrey W. Fisher, David G. Hoel, Lawrence C. Mohr

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Trichloroethylene (TCE) is a widespread environmental contaminant that is carcinoenic when given in high, chronic doses to certain strains of mice and rats. The capacity of TCE to cause cancer in humans is less clear. The current maximum contaminant level (MCL) of 5 ppb (μg/L) is based on an US Environment Protection Agency (USEPA) policy decision rather than the underlying science. In view of major advances in understanding the etiology and mechanisms of chemically induced cancer, USEPA began in the late 1990s to revise its guidelines for cancer risk assessment. TCE was chosen as the pilot chemical. The USEPA (2005) final guidelines emphasized a "weight-of-evidence" approach with consideration of dose-response relationships, modes of action, and metabolic/toxicokinetic processes. Where adequate data are available to support reversible binding of the carcinogenic moiety to biological receptors as the initiating event (i.e., a threshold exists), a nonlinear approach is to be used. Otherwise, the default assumption of a linear (i.e., nonthreshold) dose-response is utilized. When validated physiologically based pharmacokinetic (PBPK) models are available, they are to be used to predict internal dosimetry as the basis for species and dose extrapolations. The present article reviews pertinent literature and discusses areas where research may resolve some outstanding issues and facilitate the reassessment process. Key research needs are proposed, including role of dichloroacetic acid (DCA) in TCE-induced liver tumorigenesis in humans; extension of current PBPK models to predict target organ deposition of trichloroacetic acid (TCA) and DCA in humans ingesting TCE in drinking water; use of human hepatocytes to ascertain metabolic rate constants for use in PBPK models that incorporate variability in metabolism of TCE by potentially sensitive subpopulations; measurement of the efficiency of first-pass elimination of trace levels of TCE in drinking water; and assessment of exogenous factors' (e.g., alcohol, drugs) ability to alter metabolic activation and risks at such low-level exposure.

Original languageEnglish (US)
Pages (from-to)782-797
Number of pages16
JournalCritical reviews in toxicology
Volume39
Issue number9
DOIs
StatePublished - Nov 12 2009

Fingerprint

Trichloroethylene
Risk assessment
Pharmacokinetics
Dichloroacetic Acid
Drinking Water
Dosimetry
Guidelines
Impurities
Neoplasms
Trichloroacetic Acid
Research
Extrapolation
Metabolism
Liver
Rats
Hepatocytes
Rate constants
Carcinogenesis
Chemical activation
Alcohols

Keywords

  • Carcinogenesis
  • PBPK modeling
  • Peroxisome proliferation
  • Presystemic elimination
  • Risk assessment
  • Trichloroethylene

ASJC Scopus subject areas

  • Toxicology

Cite this

Jollow, D. J., Bruckner, J. V., McMillan, D. C., Fisher, J. W., Hoel, D. G., & Mohr, L. C. (2009). Trichloroethylene risk assessment: A review and commentary. Critical reviews in toxicology, 39(9), 782-797. https://doi.org/10.3109/10408440903222177

Trichloroethylene risk assessment : A review and commentary. / Jollow, David J.; Bruckner, James V.; McMillan, David C.; Fisher, Jeffrey W.; Hoel, David G.; Mohr, Lawrence C.

In: Critical reviews in toxicology, Vol. 39, No. 9, 12.11.2009, p. 782-797.

Research output: Contribution to journalReview article

Jollow, DJ, Bruckner, JV, McMillan, DC, Fisher, JW, Hoel, DG & Mohr, LC 2009, 'Trichloroethylene risk assessment: A review and commentary', Critical reviews in toxicology, vol. 39, no. 9, pp. 782-797. https://doi.org/10.3109/10408440903222177
Jollow, David J. ; Bruckner, James V. ; McMillan, David C. ; Fisher, Jeffrey W. ; Hoel, David G. ; Mohr, Lawrence C. / Trichloroethylene risk assessment : A review and commentary. In: Critical reviews in toxicology. 2009 ; Vol. 39, No. 9. pp. 782-797.
@article{d8ac2c0399bd45719852c0272b3784a3,
title = "Trichloroethylene risk assessment: A review and commentary",
abstract = "Trichloroethylene (TCE) is a widespread environmental contaminant that is carcinoenic when given in high, chronic doses to certain strains of mice and rats. The capacity of TCE to cause cancer in humans is less clear. The current maximum contaminant level (MCL) of 5 ppb (μg/L) is based on an US Environment Protection Agency (USEPA) policy decision rather than the underlying science. In view of major advances in understanding the etiology and mechanisms of chemically induced cancer, USEPA began in the late 1990s to revise its guidelines for cancer risk assessment. TCE was chosen as the pilot chemical. The USEPA (2005) final guidelines emphasized a {"}weight-of-evidence{"} approach with consideration of dose-response relationships, modes of action, and metabolic/toxicokinetic processes. Where adequate data are available to support reversible binding of the carcinogenic moiety to biological receptors as the initiating event (i.e., a threshold exists), a nonlinear approach is to be used. Otherwise, the default assumption of a linear (i.e., nonthreshold) dose-response is utilized. When validated physiologically based pharmacokinetic (PBPK) models are available, they are to be used to predict internal dosimetry as the basis for species and dose extrapolations. The present article reviews pertinent literature and discusses areas where research may resolve some outstanding issues and facilitate the reassessment process. Key research needs are proposed, including role of dichloroacetic acid (DCA) in TCE-induced liver tumorigenesis in humans; extension of current PBPK models to predict target organ deposition of trichloroacetic acid (TCA) and DCA in humans ingesting TCE in drinking water; use of human hepatocytes to ascertain metabolic rate constants for use in PBPK models that incorporate variability in metabolism of TCE by potentially sensitive subpopulations; measurement of the efficiency of first-pass elimination of trace levels of TCE in drinking water; and assessment of exogenous factors' (e.g., alcohol, drugs) ability to alter metabolic activation and risks at such low-level exposure.",
keywords = "Carcinogenesis, PBPK modeling, Peroxisome proliferation, Presystemic elimination, Risk assessment, Trichloroethylene",
author = "Jollow, {David J.} and Bruckner, {James V.} and McMillan, {David C.} and Fisher, {Jeffrey W.} and Hoel, {David G.} and Mohr, {Lawrence C.}",
year = "2009",
month = "11",
day = "12",
doi = "10.3109/10408440903222177",
language = "English (US)",
volume = "39",
pages = "782--797",
journal = "Critical Reviews in Toxicology",
issn = "1040-8444",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Trichloroethylene risk assessment

T2 - A review and commentary

AU - Jollow, David J.

AU - Bruckner, James V.

AU - McMillan, David C.

AU - Fisher, Jeffrey W.

AU - Hoel, David G.

AU - Mohr, Lawrence C.

PY - 2009/11/12

Y1 - 2009/11/12

N2 - Trichloroethylene (TCE) is a widespread environmental contaminant that is carcinoenic when given in high, chronic doses to certain strains of mice and rats. The capacity of TCE to cause cancer in humans is less clear. The current maximum contaminant level (MCL) of 5 ppb (μg/L) is based on an US Environment Protection Agency (USEPA) policy decision rather than the underlying science. In view of major advances in understanding the etiology and mechanisms of chemically induced cancer, USEPA began in the late 1990s to revise its guidelines for cancer risk assessment. TCE was chosen as the pilot chemical. The USEPA (2005) final guidelines emphasized a "weight-of-evidence" approach with consideration of dose-response relationships, modes of action, and metabolic/toxicokinetic processes. Where adequate data are available to support reversible binding of the carcinogenic moiety to biological receptors as the initiating event (i.e., a threshold exists), a nonlinear approach is to be used. Otherwise, the default assumption of a linear (i.e., nonthreshold) dose-response is utilized. When validated physiologically based pharmacokinetic (PBPK) models are available, they are to be used to predict internal dosimetry as the basis for species and dose extrapolations. The present article reviews pertinent literature and discusses areas where research may resolve some outstanding issues and facilitate the reassessment process. Key research needs are proposed, including role of dichloroacetic acid (DCA) in TCE-induced liver tumorigenesis in humans; extension of current PBPK models to predict target organ deposition of trichloroacetic acid (TCA) and DCA in humans ingesting TCE in drinking water; use of human hepatocytes to ascertain metabolic rate constants for use in PBPK models that incorporate variability in metabolism of TCE by potentially sensitive subpopulations; measurement of the efficiency of first-pass elimination of trace levels of TCE in drinking water; and assessment of exogenous factors' (e.g., alcohol, drugs) ability to alter metabolic activation and risks at such low-level exposure.

AB - Trichloroethylene (TCE) is a widespread environmental contaminant that is carcinoenic when given in high, chronic doses to certain strains of mice and rats. The capacity of TCE to cause cancer in humans is less clear. The current maximum contaminant level (MCL) of 5 ppb (μg/L) is based on an US Environment Protection Agency (USEPA) policy decision rather than the underlying science. In view of major advances in understanding the etiology and mechanisms of chemically induced cancer, USEPA began in the late 1990s to revise its guidelines for cancer risk assessment. TCE was chosen as the pilot chemical. The USEPA (2005) final guidelines emphasized a "weight-of-evidence" approach with consideration of dose-response relationships, modes of action, and metabolic/toxicokinetic processes. Where adequate data are available to support reversible binding of the carcinogenic moiety to biological receptors as the initiating event (i.e., a threshold exists), a nonlinear approach is to be used. Otherwise, the default assumption of a linear (i.e., nonthreshold) dose-response is utilized. When validated physiologically based pharmacokinetic (PBPK) models are available, they are to be used to predict internal dosimetry as the basis for species and dose extrapolations. The present article reviews pertinent literature and discusses areas where research may resolve some outstanding issues and facilitate the reassessment process. Key research needs are proposed, including role of dichloroacetic acid (DCA) in TCE-induced liver tumorigenesis in humans; extension of current PBPK models to predict target organ deposition of trichloroacetic acid (TCA) and DCA in humans ingesting TCE in drinking water; use of human hepatocytes to ascertain metabolic rate constants for use in PBPK models that incorporate variability in metabolism of TCE by potentially sensitive subpopulations; measurement of the efficiency of first-pass elimination of trace levels of TCE in drinking water; and assessment of exogenous factors' (e.g., alcohol, drugs) ability to alter metabolic activation and risks at such low-level exposure.

KW - Carcinogenesis

KW - PBPK modeling

KW - Peroxisome proliferation

KW - Presystemic elimination

KW - Risk assessment

KW - Trichloroethylene

UR - http://www.scopus.com/inward/record.url?scp=70449135026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449135026&partnerID=8YFLogxK

U2 - 10.3109/10408440903222177

DO - 10.3109/10408440903222177

M3 - Review article

C2 - 19852561

AN - SCOPUS:70449135026

VL - 39

SP - 782

EP - 797

JO - Critical Reviews in Toxicology

JF - Critical Reviews in Toxicology

SN - 1040-8444

IS - 9

ER -